Hey Market Enthusiast,
Â
Something unusual is setting up in the biotech space tonight.
Â
One small-cap name with a novel antiviral platform just delivered breakthrough data — and the timing couldn’t be tighter.
Â
The science addresses a fast-spreading public-health story, the chart is coiled after months of compression, and word is spreading fast.
Â
Last
time we spotlighted this name, it climbed 12% from the previous close to the day’s high.
Â
Tomorrow morning at 8AM, the full report drops.
Â
Be early this time. Our last one saw an early 10%+ run….
Â
👉 Watch your inbox.
Â
Max Masters
Co-founder, Market Tips Newsletter
Â